NO20065101L - Forbindelse WS727713 - Google Patents

Forbindelse WS727713

Info

Publication number
NO20065101L
NO20065101L NO20065101A NO20065101A NO20065101L NO 20065101 L NO20065101 L NO 20065101L NO 20065101 A NO20065101 A NO 20065101A NO 20065101 A NO20065101 A NO 20065101A NO 20065101 L NO20065101 L NO 20065101L
Authority
NO
Norway
Prior art keywords
compound
relates
present
pseudonocardia
culturing
Prior art date
Application number
NO20065101A
Other languages
English (en)
Inventor
Takanao Otsuka
Hirotsugu Ueda
Keiko Fujie
Hideyuki Muramatsu
Michizane Hashimoto
Shigehiro Takase
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004901919A external-priority patent/AU2004901919A0/en
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of NO20065101L publication Critical patent/NO20065101L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00—Subject matter not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Abstract

Den foreliggende oppfinnelsen angår en ny forbindelse som er nyttig som modulator av melanokortinreseptorer. Den foreliggende oppfinnelsen angår især en forbindelse WS727713, en fremgangsmåte for fremstilling av forbindelsen ved dyrking, i et dyrkingsmedium, en WS727713-produserende stamme tilhørende Pseudonocardia- slekten og utvinne forbindelsen fra en dyrkingsvæske,. et farmasøytisk preparat som inneholder forbindelsen, bruk av forbindelsen for fremstilling av et legemiddel eller kosmetikk for melanokortinreseptormodulering, bruk av forbindelsen for fremstilling av et medikament eller kosmetikk for behandling eller forebyggelse av iskemi-/reperfusjonsskade, inflammatoriske hjerne- og nyresykdommer, hepatitt, sepsis/septisk sjokk, hypoksisk sjokk, akutt respiratorisk stressyndrom (ARDS), revmatisk artritt (RA), giktartritt, aortaregurgitasjon (AR), juvenil kronisk artritt, osteoartritt, nefritt, induksjon av toleranse, kontakthypersensitivitet, inflammatorisk tarmsykdom (IBD), seksuell dysfunksjon, transplantasjon, smerte, sykdomsprogresjon av HIV, postinflammatorisk hypopigmentasjon, tinea versicolor, idiopatisk guttat hypomelanose, feber, funksjonell tarmsykdom, overvekt, metthetseffekt, diabetes mellitus, modulering av dermal eksokrin funksjon, kanitis (canities circumscripta), grått hår, pankreatitt, fibrotiske lidelser (hypertropiske arr, keloider, lokalisert skierodermi, systematisk sklerose, sklerodermisk transplantat-mot-vert hudsykdom, levercirrhose, idiopatisk og bleomysinindusert lungefibrose, sykolsporinindusert nevropati), uveitt (spesielt ved Behcets syndrom og sarkoidose), vaskulitt, mikrobielle infeksjoner, cøliaki, vulvar vestibulittsyndrom, melanom invasjon, anoreksi eller noe lignende.
NO20065101A 2004-04-08 2006-11-06 Forbindelse WS727713 NO20065101L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2004901919A AU2004901919A0 (en) 2004-04-08 New Compound
PCT/JP2005/005653 WO2005097973A1 (en) 2004-04-08 2005-03-22 Compound ws 727713

Publications (1)

Publication Number Publication Date
NO20065101L true NO20065101L (no) 2006-11-06

Family

ID=34961861

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065101A NO20065101L (no) 2004-04-08 2006-11-06 Forbindelse WS727713

Country Status (21)

Country Link
US (3) US7741085B2 (no)
EP (1) EP1751273B1 (no)
JP (3) JP4793265B2 (no)
KR (4) KR20100118615A (no)
CN (1) CN1977040B (no)
AT (1) ATE498678T1 (no)
BR (1) BRPI0508787A (no)
CA (1) CA2563498C (no)
DE (1) DE602005026380D1 (no)
DK (1) DK1751273T3 (no)
ES (1) ES2358352T3 (no)
HK (1) HK1103420A1 (no)
IL (1) IL178476A0 (no)
MX (1) MXPA06011521A (no)
NO (1) NO20065101L (no)
PL (1) PL1751273T3 (no)
PT (1) PT1751273E (no)
RU (1) RU2407785C2 (no)
TW (1) TWI352736B (no)
WO (1) WO2005097973A1 (no)
ZA (1) ZA200609241B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030006199A (ko) * 2001-07-12 2003-01-23 남기철 고순도 칼슘 수용액의 제조방법 및 그로부터 생성된고순도 칼슘 수용액
KR20020057845A (ko) * 2002-04-09 2002-07-12 (주)마이크로쉘 탄산칼슘류의 제조에 있어서 브로어를 이용한 이송방법 및마이크로파를 이용한 입도제어기술
DE602005026380D1 (de) * 2004-04-08 2011-03-31 Astellas Pharma Inc Verbindung ws727713
RU2500410C2 (ru) * 2011-08-05 2013-12-10 Виктор Владимирович Редькин Применение лизата актиномицетов для приготовления наружных средств ухода за ногтями
CN102296039B (zh) * 2011-08-12 2013-04-24 中国科学院南海海洋研究所 一种假诺卡氏菌及利用其制备Deoxynyboquinone的方法
JP2013180961A (ja) * 2012-02-29 2013-09-12 Astellas Pharma Inc Ｗｓ７２７７１３含有固形製剤
US10232018B2 (en) 2013-03-14 2019-03-19 Mallinckrodt Ard Ip Limited ACTH for treatment of acute respiratory distress syndrome

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795788A (nl) 1972-02-22 1973-08-22 Akzo Nv Werkwijze ter bereiding van peptiden en peptide-derivaten en de toepassing hiervan
JPS58138380A (ja) 1982-02-12 1983-08-17 Dainippon Ink & Chem Inc 微生物
JPS58179498A (ja) 1982-04-13 1983-10-20 Dainippon Ink & Chem Inc 微生物による１１α−ヒドロキシル化アンドロスタン系化合物の製造方法
DE19532317A1 (de) * 1995-09-01 1997-03-06 Haarmann & Reimer Gmbh Verfahren zur Herstellung von Vanillin und dafür geeignete Mikroorganismen
US6074872A (en) * 1996-05-15 2000-06-13 The Scripps Research Institute Cortistatin: nucleic acids that encode these neuropeptides
EP1040351B1 (en) * 1997-12-16 2007-07-18 Merck & Co., Inc. C-terminal region of agouti-related transcript (art) protein
EP1076649A4 (en) * 1998-04-28 2010-06-02 Trega Biosciences Inc ISOQUINOLINE-BASED COMPOUNDS IN PLACE OF MELANOCORTIN RECEPTOR LIGANDS AND METHODS OF USE
WO2000033658A1 (en) * 1998-12-09 2000-06-15 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
MXPA02007289A (es) * 2000-01-28 2003-09-22 Melacure Therapeutics Ab Agonistas y antagonistas novedosos de receptores de melanocortina.
EA200201119A1 (ru) * 2000-06-28 2003-06-26 Пфайзер Продактс Инк. Лиганды меланокортиновых рецепторов
BR0113637A (pt) * 2000-08-30 2004-02-25 Hoffmann La Roche Composto, processo para a preparação desse composto, composição farmacêutica que compreende o mesmo, utilização do composto, processo para o tratamento e/ou profilaxia de enfermidade que estão associadas com a atividade de receptor melanocortin-4
KR100681670B1 (ko) * 2001-02-14 2007-02-09 주식회사 엘지생활건강 [감마 히드록시 엔- 메틸-엘-루신9]사이클로스포린 에이를유효성분으로 하는 모발 성장 촉진제
DE602005026380D1 (de) * 2004-04-08 2011-03-31 Astellas Pharma Inc Verbindung ws727713

Also Published As

Publication number Publication date
TWI352736B (en) 2011-11-21
RU2006139138A (ru) 2008-05-20
KR20100051751A (ko) 2010-05-17
TW200602066A (en) 2006-01-16
US20100297735A1 (en) 2010-11-25
KR20100118615A (ko) 2010-11-05
JP5721516B2 (ja) 2015-05-20
EP1751273A1 (en) 2007-02-14
JP2011201884A (ja) 2011-10-13
KR20110086647A (ko) 2011-07-28
CA2563498A1 (en) 2005-10-20
US20070254829A1 (en) 2007-11-01
HK1103420A1 (en) 2007-12-21
IL178476A0 (en) 2007-02-11
KR101176758B1 (ko) 2012-08-23
CN1977040A (zh) 2007-06-06
US8133713B2 (en) 2012-03-13
PT1751273E (pt) 2011-03-07
JP2007532476A (ja) 2007-11-15
MXPA06011521A (es) 2007-03-21
JP4793265B2 (ja) 2011-10-12
JP2014040456A (ja) 2014-03-06
CA2563498C (en) 2013-05-21
KR101092716B1 (ko) 2011-12-09
DK1751273T3 (da) 2011-05-02
EP1751273B1 (en) 2011-02-16
US20120214731A1 (en) 2012-08-23
BRPI0508787A (pt) 2007-09-04
US7741085B2 (en) 2010-06-22
RU2407785C2 (ru) 2010-12-27
PL1751273T3 (pl) 2011-07-29
WO2005097973A1 (en) 2005-10-20
US8592378B2 (en) 2013-11-26
KR20070008682A (ko) 2007-01-17
CN1977040B (zh) 2011-01-12
ZA200609241B (en) 2008-06-25
ATE498678T1 (de) 2011-03-15
ES2358352T3 (es) 2011-05-09
DE602005026380D1 (de) 2011-03-31

Similar Documents

Publication Publication Date Title
NO20065101L (no) Forbindelse WS727713
BRPI0506369A (pt) microorganismos, e, métodos para produzir um l-aminoácido
EA200900286A1 (ru) Модификация бактерий для получения этанола
GB2441718A (en) Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells
MY175283A (en) Mutant microorganisms having high ability to produce putrescine and method for producing putrescine using the same
ATE524161T1 (de) Zusammensetzung mit einem gekoppelten enzymsystem
BRPI0818528A8 (pt) Aumento do rendimento da metionina
BR112012016318A2 (pt) "alfa-amilase isolada, composição, método pra produzir amido liquefeito, processo para sintetizar um produto de fermentação, sequência de acidos nucleicos, célula hospedeira, e, método para preparar uma alfa-amilase."
NZ593907A (en) Treating collagen-mediated diseases with Clostidium histolyticum collagenase I and II
TR201903336T4 (tr) Fermantasyonda gelişmiş karbon yakalama.
PL2235194T3 (pl) Sposób fermentacyjnego wytwarzania 1,5- diaminopentanu
WO2013115659A3 (en) Recombinant microorganisms and methods of use thereof
UA110600C2 (uk) Спосіб отримання захищених похідних l-аланіну
WO2009073557A3 (en) Biological systems for production of commercially valuable compounds
ATE469976T1 (de) Mikrobielle vitamin-c-produktion
ATE370224T1 (de) Verfahren zur herstellung von l-cystein unter verwendung eines zur gattung escherichia gehörenden bakteriums
MX2007010141A (es) Procesos para la preparacion de intermedios de linezolid.
FR3020379B1 (fr) Procede de production de methane par co-culture aerobie de microorganismes anaerobies
EA201491785A1 (ru) Способ ферментации
NO20075911L (no) Genetisk modifisert mikroorganisme og fremgangsmate for fremstilling av makrolidforbindelser ved anvendelse av mikroorganismen
EA200900984A1 (ru) Улучшение клеточного роста
WO2009120806A3 (en) Expression of oxidoreductases to increase volumetric productivity
WO2010064262A3 (en) A process for production of water soluble melanin using a strain of the fungus gliocephalotrichum
EA201101179A1 (ru) Молекула нуклеиновой кислоты биосинтетического кластера, кодирующая нерибосомальные пептидсинтазы, и ее применение
EA201070087A1 (ru) СПОСОБ СИНТЕЗА 9α-ГИДРОКСИСТЕРОИДОВ

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application